Project Grant R41GM148104

Award Date 9/1/22
Completion Date 8/31/25
Dollars Obligated $800K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19146, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $306,860 to Mixedlcmedia LLC, a small disadvantaged business, to develop and evaluate a prototype ultra-low flow liquid chromatography platform based on their proprietary porous layer open-tubular (PLOT) and monolithic nanocolumn technologies. The goal is to create a commercialization-ready LC system that enables deep proteomic...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA program 93.859 Biomedical Research and Research Training provides $350,000 to Fluidispec LLC to develop a new microfluidic/nanofluidic sample preparation platform. The goal is to improve single-cell and low-input proteomics analysis by enabling efficient extraction of proteins from cells, removal of contaminants, and improved protein denaturation. This platform is expected to enhance...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $2,297,901 to GMJ Technologies, Inc., a minority-owned small disadvantaged business, to develop a high-resolution native capillary zone electrophoresis system with inline UV and native mass spectrometry capabilities. This innovative analytical technology aims to enhance the characterization and quality control of protein...
This $350,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development and optimization of a novel, enzyme-based, single-molecule protein sequencing system by Electronic Biosciences, Inc. The objective is to create a rapid, reliable, and cost-effective platform that can accurately sequence proteins, including those with post-translational modifications, through the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of their Plasmonic Scattering Microscopy (PSM) technology. The PSM system aims to enable high-throughput, label-free quantification of membrane protein binding kinetics on single cells in their native cellular microenvironment. This represents a...
Partillion Bioscience Corp. was awarded a $659,037 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences to develop reagent products enabling high-throughput screening and selection of single cells based on secreted bio-products. Under the Biomedical Research and Research Training program (CFDA 93.859), Partillion plans to transition its lab-on-a-particle technology—highlighted as a 2020 SLAS Innovation Award winner—into the first reagent product...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
This National Science Foundation (NSF) Biological Sciences grant award provides $2,225,964 to the Georgia Tech Research Corporation (Georgia Tech) to develop a novel biosensing platform called "protocell communities" that can be used for rapid, low-cost medical diagnostics. The project aims to create a tool that can diagnose medical conditions by detecting and integrating multiple indicator molecules, addressing limitations of single-analyte diagnostics. The protocell technology uses...
The Arizona State University was awarded a $2,678,944 Project Grant from the Department of Health and Human Services Assistant Secretary for Financial Resources' Biomedical Research and Research Training program (CFDA 93.859) to develop an integrated nano-opto-fluidic system on sapphire for single-molecule protein sequencing from September 1, 2022 to August 31, 2025. The University will design an on-chip electronic system incorporating nano-opto-fluidic structures to transduce protein...
The National Institute of General Medical Sciences (NIGMS) awarded a $358,862 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to GMJ Technologies, Inc., a minority-owned small business, to develop a microfluidic SDS depletion electrophoresis (SDE) interface. This interface will enable direct coupling of capillary electrophoresis with sodium dodecyl sulfate (CE-SDS) to mass spectrometry for improved characterization and quality control of monoclonal...

A MICROFLUIDIC/NANOFLUIDIC SYSTEM FOR RAPID SINGLE CELL PROTEOMICS - PROTEOMICS TYPICALLY INVOLVES THE ANALYSIS OF THE PROTEIN COMPONENTS OF LARGE POPULATIONS OF CELLS. NEARLY ALL THE OF A CELL'S MACHINERY ARE PROTEINS, SO MANY DISEASES AND RESPONSES TO STIMULI AND STRESSORS ARE MANIFESTED AT THE PROTEIN LEVEL. PROTEOMES ARE CHALLENGING TO CHARACTERIZE FULLY FOR MANY REASONS. SOME OF THE KEY ATTRIBUTES OF A PROTEOME THAT MAKE ITS CHARACTERIZATION SO CHALLENGING ARE: THE LARGE NUMBER OF PROTEINS EXPRESSED IN A SINGLE CELL, THE WIDE DYNAMIC RANGE OF PROTEIN RELATIVE ABUNDANCE, AND THE NUMEROUS MODIFICATIONS THAT CAN SWITCH PROTEINS BETWEEN ACTIVE AN INACTIVE STATES. TO FURTHER INCREASE COMPLEXITY, SIGNIFICANT HETEROGENEITY EXISTS AT THE CELLULAR LEVEL THAT IS AVERAGED OUT BY BULK ANALYSES. TO BETTER UNDERSTAND BIOLOGICAL AND HEALTH IMPLICATIONS OF CELLULAR HETEROGENEITY, SINGLE CELL PROTEOMICS HAS EMERGED. HOWEVER, IMPROVEMENTS IN THE ENABLING ANALYTICAL TECHNOLOGIES ARE NEEDED AS SINGLE-CELL PROTEOMICS ADDS THE ADDITIONAL CHALLENGE OF EXTREMELY SMALL SAMPLE SIZE. THIS APPLICATION FOCUSES ON THE DEVELOPMENT OF A NOVEL ELECTROKINETIC MICROFLUIDIC/NANOFLUIDIC SYSTEM FOR IMPROVED SINGLE-CELL PROTEOME ANALYSES THAT IS A SIGNIFICANT DEVIATION FROM THE CURRENT ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY (UPLC)-MASS SPECTROMETRY (MS) BASED APPROACHES. THE PROPOSED ELECTROKINETIC MICROFLUIDIC/NANOFLUIDIC SYSTEM IS EXPECTED TO OFFER IMPROVED PERFORMANCE FROM: REDUCED SAMPLE LOSS, INCREASED SAMPLE CONCENTRATION ELUTED INTO THE MASS SPECTROMETER, REDUCED PEPTIDE CONTAMINATION, HIGH EFFICIENCY SEPARATIONS, AND RAPID ANALYSES. THE AIMS OF THIS APPLICATION FOCUS ON: 1) FABRICATION AND OPTIMIZATION OF THE KEY FUNCTIONAL MODULES, AND 2) INTEGRATION OF THESE FUNCTIONAL MODULES INTO A COMPLETE SYSTEM AND MEASUREMENT OF THE PERFORMANCE OF THE COMPLETE SYSTEM. THE PRIMARY METRICS FOR SYSTEM PERFORMANCE WILL BE THE SPEED OF THE ANALYSIS AND THE NUMBER OF PROTEIN GROUPS IDENTIFIED. IF SUCCESSFUL, THIS APPLICATION WILL PROVIDE A NOVEL SYSTEM FOR SINGLE-CELL PROTEOMICS THAT WILL IMPROVE THE ANALYSIS SPEED WITHOUT SACRIFICING DEPTH OF PROTEOME COVERAGE.

Posted 8/23/22, 12:00 AM